Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Dillon

Showing results (141-150 of 176) with videos related to

Pageof 18
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2019
The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward EliminationKelly Safreed-Harmon, Sarah Blach, Soo Aleman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 5, 2020
Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus InfectionEli Zuckerman, Julio A Gutierrez, Douglas E Dylla, et al.
Journal of Hepatology|August 23, 2016
Mortality in hepatitis C patients who achieve a sustained viral response compared to the general populationHamish Innes, Scott McDonald, Peter Hayes, et al.
Gut|November 11, 2017
Guidelines on the management of abnormal liver blood testsPhilip N Newsome, Rob Cramb, Suzanne M Davison, et al.
The Lancet. Gastroenterology & Hepatology|March 1, 2024
Progress is impossible without change: understanding the evolving nomenclature of steatotic liver disease and its effect on hepatology practicePaul N Brennan, Oliver D Tavabie, Wenhao Li, et al.
Drug and Alcohol Dependence|July 18, 2015
Evidence of continued injecting drug use after attaining sustained treatment-induced clearance of the hepatitis C virus: Implications for reinfectionHeather Valerio, David J Goldberg, James Lewsey, et al.
Gut|March 29, 2020
Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage studySharon J Hutchinson, Heather Valerio, Scott A McDonald, et al.
Hepatology (Baltimore, Md.)|February 27, 2015
Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomesHamish A Innes, Scott A McDonald, John F Dillon, et al.
BMJ Open|November 9, 2021
Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH)Paul Noel Brennan, Mark MacMillan, Thomas Manship, et al.
Nature Reviews. Gastroenterology & Hepatology|January 30, 2026
Lessons learned from viral hepatitis testing that inform law and policy responses to steatotic liver diseaseJeffrey V Lazarus, Christopher J Kopka, Aina Nicolàs, et al.
Pageof 18

Showing results (141-150 of 176) with videos related to

Sort By:
Pageof 18
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2019
The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward EliminationKelly Safreed-Harmon, Sarah Blach, Soo Aleman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 5, 2020
Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus InfectionEli Zuckerman, Julio A Gutierrez, Douglas E Dylla, et al.
Journal of Hepatology|August 23, 2016
Mortality in hepatitis C patients who achieve a sustained viral response compared to the general populationHamish Innes, Scott McDonald, Peter Hayes, et al.
Gut|November 11, 2017
Guidelines on the management of abnormal liver blood testsPhilip N Newsome, Rob Cramb, Suzanne M Davison, et al.
The Lancet. Gastroenterology & Hepatology|March 1, 2024
Progress is impossible without change: understanding the evolving nomenclature of steatotic liver disease and its effect on hepatology practicePaul N Brennan, Oliver D Tavabie, Wenhao Li, et al.
Drug and Alcohol Dependence|July 18, 2015
Evidence of continued injecting drug use after attaining sustained treatment-induced clearance of the hepatitis C virus: Implications for reinfectionHeather Valerio, David J Goldberg, James Lewsey, et al.
Gut|March 29, 2020
Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage studySharon J Hutchinson, Heather Valerio, Scott A McDonald, et al.
Hepatology (Baltimore, Md.)|February 27, 2015
Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomesHamish A Innes, Scott A McDonald, John F Dillon, et al.
BMJ Open|November 9, 2021
Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH)Paul Noel Brennan, Mark MacMillan, Thomas Manship, et al.
Nature Reviews. Gastroenterology & Hepatology|January 30, 2026
Lessons learned from viral hepatitis testing that inform law and policy responses to steatotic liver diseaseJeffrey V Lazarus, Christopher J Kopka, Aina Nicolàs, et al.
Pageof 18